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In this work we introduce and analyze a generalized model of precursor T-lymphoblastic
lymphoma as a competition between two clonotypes of naïve T-cells, one “normal” and one
tumorous. It is modeled as a continuous-time bivariate Markov process. Using an expansion
of the master equation a deterministic approximation and the Fokker–Planck equation are
derived. For a deterministic model we show existence and uniqueness of global solutions
and positive invariance of the ﬁrst quadrant of the phase space. Stability analysis of the
model is performed, ﬁnding conditions guaranteeing existence of a unique, positive, steady
state, which is proved to be globally stable. It is shown that expectations of ﬂuctuations
for both clonotypes tend to zero for large time. We also present numerical simulations
in which two types of behavior of solutions are observed: either both clonotypes survive
in the repertoire or the “normal” clonotype becomes extinct. Comparing this result with
the rules of maintenance of naïve T-cell repertoire, which say that clonotypes with more
speciﬁc set of receptors have longer life-span, it seems that “normal” clonotype follows
them, whereas the tumorous one violates them and tends to the maximum possible
expansion. The model supports the hypothesis of mutated precursor cells as an origin of
cancer.
© 2011 Elsevier Inc. All rights reserved.
1. Introduction
From the 1950s it is known that only a few cells are suﬃcient to initiate and maintain a cancer (see e.g. [1]). Char-
acteristics of these cells coincide with deﬁnition of stem cells, which can self-renew limitlessly thanks to their ability to
undergo a symmetrical cell division resulting in two identical daughter stem cells or an asymmetrical cell division resulting
in one stem cell and one more differentiated progenitor cell. This way stem cells give the origin to all the cells of the body
meanwhile their population does not deplete (see e.g. [2]). For example all blood cells, although utterly different from each
other, originate from one type of cells: hematopoietic stem cells (HSCs). Practical consequences of the extraordinary capa-
bilities of stem cells can be observed in experiments where bone marrow of mice was destroyed by radiation. Injection of
differentiated blood cells or progenitor cells does not have any long-term effect, meanwhile introduction of a single HSC can
rebuild the whole blood system of the animal, see [3]. Similar result was observed for cancer in the experiment carried out
by a group of investigators from University of Toronto in 1971, see [4]. They discovered that proliferation rate of tumor cells
within one sample differed signiﬁcantly. Moreover, only some of the cancer cells gave origin to a neoplasm when injected
into naïve mice. These results supported the hypothesis of existence of cancer stem cells, which were found for the ﬁrst
time in 1994 for acute myeloblastic leukemia (AML), [5] and for many different types of cancer in subsequent years. The
origin of these cells still remains an enigma. There exist two hypotheses. The ﬁrst one says that stem cells lose control over
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changes in DNA which turns them into a potential source of a tumor. The second hypothesis claims that mutations occur
in progenitor cells causing the recuperation of their self-renewal capability. In any case, these mutated cells are the real
origin of the illness. The main mass of a tumor consists of differentiated cells, which have short lifetimes and almost cannot
proliferate. If any of them was injected into experimental animal, it would not create a cancer. So, stem cells as a constant
and very eﬃcient source of new differentiated cells are responsible for the evolution and maintenance of the neoplasm.
Hence, the control over cancer can be achieved only by controlling the population of its stem cells [6].
Cancer is an extremely broad term. It encompasses more than 200 types of malignancies, each of them with unique
features, causes, evolution and speciﬁc treatment. In the last forty years a great number of mathematical models of cancer
have been developed (see [7]) to serve as a tool of modeling and prediction for many different aspects of this illness (see
e.g. [8–10] and the references therein), like avascular growth (e.g. [11] and the references therein), necrotic core formation
(e.g. [12] and the references therein), angiogenesis (e.g. [13–15] and the references therein), cancer–immune system interac-
tions (e.g. [10,16–21] and the references therein), mutations (e.g. [22] or [23] and the references therein), or general tumor
growth (e.g. [7–9,24–28] and the references therein). Various mathematical tools are used to model tumor growth. Deter-
ministic models are written on the basis of kinetic and partial differential equations (e.g. [29] or [24] and the references
therein), ordinary or delay differential equations (e.g. [11,13,16,17,25,23] and the references therein). Also stochastic models
are used, see for example [30–33] and the references therein. Some of the most recent topics include studies of angiogenesis
(e.g. [15]), chemotherapy (e.g. [34]), chemo- and haptotaxis (e.g. [26,27]), interaction between cancer and immune system
(e.g. [21]) and tumor invasion (e.g. [28]). Many models refer to cancer as a general problem, not specifying any particular
kind of the illness. In our opinion, due to diversity of the processes associated with evolution of a tumor, one should focus
on the particular type of cancer in order to achieve a good agreement with medical reality. Therefore, in this work we study
a generalized model of precursor T-lymphoblastic lymphoma, which is a type of non-Hodgkin lymphoma and it is a cancer
of T-cells [35]. These cells originate from hematopoietic stem cells in the bone marrow. During their evolution they migrate
to thymus, where they pass a test excluding the non-functional or overactive ones. Once they leave thymus, T-cells form
a part of naïve T-cell repertoire. They continuously recirculate peripheral lymph nodes and tissues, waiting for an encounter
with professional, antigen presenting cells (APCs). APCs display on their surface self and foreign peptides. The antigen pre-
sentation proﬁle of an APC is called APP. It can be read by T-cells thanks to surface peptide receptors (TCRs). This is an
activation signal for them and it leads to proliferation and differentiation into effector T-cells [36–38]. As immune system
cannot predict to which pathogens the organism will be exposed during its lifetime, TCR diversity is randomly generated by
genetic recombination [39]. A group of T-cells with identical TCR molecules is called a clonotype. There might exist certain
similarities between different clonotypes, so they might be able to read the same type of survival stimuli from APCs. This is
the reason why T-cells compete for signals to divide that are provided by professional cells [40].
This paper is organized as follows. In the next part of Section 1 we introduce a stochastic model for two clonotypes
competing with each other and with other clonotypes from the naïve repertoire for the survival stimuli and we show per-
cell birth and death rates of the bivariate competition process. In Section 2 we derive a deterministic approximation to
the stochastic model using an expansion of the master equation and we write the Fokker–Planck equation, from which we
deduce equation for the moments of ﬂuctuations. In Section 3 we discuss some basic properties of the deterministic model,
we prove the global existence of unique positive solutions and we perform stability analysis of the model excluding the
possibility of existence of limit cycles. In Section 4 we analyze behavior of the ﬁrst and second moments of the ﬂuctuations
near stationary state and we present some numerical results. In the last section we provide a short discussion and summary
of the results.
1.1. Stochastic model
The model of precursor T-lymphoblastic lymphoma which we study is based on the model of the competitive exclusion
between different clonotypes in the maintenance of the naïve T-cell repertoire developed by E.R. Stirk et al., see [41,42].
They study the dynamics of this process from stochastic point of view for a pair of clonotypes which are similar in terms
of the speciﬁc survival stimuli which they are able to receive, concentrating mainly on the case where both of them exhibit
little competition with other T-cell clonotypes in the repertoire. They prove, inter alia, that the two clonotypes are fated
to extinct and they provide a bound on mean extinction times. They also show that the competition favors the survival of
those clonotypes which are more specialized, so with TCR proﬁles that are maximally different from each other [42].
We consider a situation when the only activation signal for T-cells is self antigen presented by APCs. We model the
competition as a continuous-time bivariate Markov process [43], assuming that the clonotype 1 of naïve T-cells is “normal”
and the clonotype 2 is tumoral, so a very competitive one. We also introduce a term for a constant inﬂux of new naïve
T-cells from the thymus, which originate from mutated lymphoid stem cells. We denote the number of cells belonging to
the clonotype i as ni(t), for i = 1,2. The income of new cells of a clonotype i from the thymus occurs within a short space
of time t̂i . The initial number of cells of the clonotype i is denoted n̂i = ni(t̂0), for some t̂0 max{t̂1, t̂2} and we assume
that n̂i = 0. Without loss of generality we may assume that t̂0 = 0. Hence the continuous-time bivariate Markov process
{X(t), Y (t): t  0} is deﬁned on the space S = {(n1,n2): n1,n2 = 0,1,2, . . .} and the initial state of the process is given
by (n1(0),n2(0)). Transitions might only occur between adjacent states and between states of cells of clonotype 2 with
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m = (m1,m2) ∈ S are given by
pnm(t) = P
(
X(t + t) =m1, Y (t + t) =m2
∣∣ X(t) = n1, Y (t) = n2).
As t → 0+ we have
pnm(t) =
⎧⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎨⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎩
λ
(1)
n1,n2t + o(t), m = (n1 + 1,n2),
λ
(2)
n1,n2t + o(t), m = (n1,n2 + 1),
α
(2)
n1,n2t + o(t), m = (n1,n2 + k),
μ
(1)
n1,n2t + o(t), m = (n1 − 1,n2),
μ
(2)
n1,n2t + o(t), m = (n1,n2 − 1),
1− (λ(1)n1,n2 + λ(2)n1,n2 + α(2)n1,n2 + μ(1)n1,n2 + μ(2)n1,n2)t, m = (n1,n2),
g(t) = o(t), otherwise,
where g(t) = o(t) as t → 0+ if limt →0+ g(t)t = 0. λ(1)n1,n2 is the birth rate of T-cells of clonotype 1 and it is the rate
of transition from state (n1,n2) to (n1 + 1,n2). Analogously, λ(2)n1,n2 is the birth rate of T-cells of clonotype 2 and the rate
transition from (n1,n2) to (n1,n2 + 1) state. α(2)n1,n2 is the rate of inﬂux of new naïve T-cells from the thymus and it is the
rate of transition from state (n1,n2) to (n1,n2 + k), where k ∈ N+ . The death rate for T-cells of clonotype 1 is denoted
by μ(1)n1,n2 and it is the rate of transition from state (n1,n2) to (n1 − 1,n2). Similarly, μ(2)n1,n2 is the death rate for T-cells of
clonotype 2 and it is the rate of transition from state (n1,n2) to (n1,n2 − 1). We set μ(1)0, j = μ(2)j,0 = 0 for all j  0. Also
λ
(1)
0, j = 0 because we assume that no T-cells of clonotype 1 are produced from the thymus after the time t = 0. Similarly we
assume that α(2)n1,n2 = 0 for any n1 and n2 < k. So, an absorbing set for this Markov process is the set of states formed by
A = {(n1,n2): n1 = 0, n2 = 0}.
Let’s denote by pn1,n2 (t) the probability that there are n1 T-cells of clonotype 1 and n2 T-cells of clonotype 2 at time t
pn1,n2(t) = P
(
X(t) = n1, Y (t) = n2
∣∣ X(0) = n̂1, Y (0) = n̂2),
with
∑+∞
n1=0
∑+∞
n2=0 pn1,n2 (t) = 1. These probabilities satisfy the forward Kolmogorov equation [43]
dpn1,n2(t)
dt
= λ(1)n1−1,n2 pn1−1,n2(t) + λ
(2)
n1,n2−1pn1,n2−1(t) + α
(2)
n1,n2−k pn1,n2−k(t) + μ
(1)
n1+1,n2 pn1+1,n2(t)
+ μ(2)n1,n2+1pn1,n2+1(t) −
(
λ
(1)
n1,n2 + λ(2)n1,n2 + α(2)n1,n2 + μ(1)n1,n2 + μ(2)n1,n2
)
pn1,n2(t). (1.1)
Next, for the bivariate competition process we derive the birth and death rates and the rate of inﬂux of new naïve T-cells
of clonotype 2 from the thymus. Following [41] the birth rates can be written as
λ
(i)
n1,n2 = ϕini
(
pi
1
n1 + n2 + ν〈n〉 + (1− pi)
1
ni + νi〈n〉
)
, for i = 1,2, (1.2)
where:
ϕi – a parameter proportional to the number of APPs from which T-cells of clonotype i receive a survival stimulus,
p1 – the probability that a randomly chosen APP provides a survival stimulus to T-cells of clonotype 2, given that it provides
a survival stimulus to T-cells of clonotype 1,
p2 – the probability that a randomly chosen APP provides a survival stimulus to T-cells of clonotype 1, given that it provides
a survival stimulus to T-cells of clonotype 2,
νi – the mean niche overlap of clonotype i, which is the average number of clonotypes that are competing with clonotype i
for an APP,
ν – the mean niche overlap of both clonotypes which is the average number of clonotypes that are competing with
clonotype 1 and clonotype 2 for an APP,
〈n〉 – the average number of T-cells per clonotype.
We model only two clonotypes of many existing. The inﬂuence of the others is modeled by parameters pi , ϕi , ν and νi . As
in [41], we assume that the average number of T-cells per clonotype is constant.
In the cases when ν 
 1 or ν1 
 1 we approximate these values by zero, so ν ≈ 0 or ν1 ≈ 0.
The per-cell death rates are assumed to be constant, so for all cases we have μ(1)n1,n2 = μ1n1 and μ(2)n1,n2 = μ2n2.
We assume that the clonotype 2 which is very competitive, so very similar to many other clonotypes in terms of the
speciﬁc survival stimuli which it is able to recognize. In other words, tumorous T-cells are less specialized in order to be
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In the next section we derive a deterministic approximation to the stochastic model presented above. Although we have in
mind the birth rates are of the form (1.2), the derivation can be made for a more general form of λ(i)n1,n2 . We assume then
that
λ
(i)
n1,n2 = ϕi f i
(
n1,n2, 〈n〉
)
, i = 1,2, (1.3)
where f i , i = 1,2, are positively homogenous functions of degree 0, this is
f i(ηx, ηy, ηz) = f i(x, y, z), i = 1,2,
for any non-negative real x, y, z and η.
2. Derivation of the deterministic equations and the Fokker–Planck equation
We use an expansion of the master equation (1.1) to derive a deterministic approximation of the stochastic model and
to calculate the ﬁrst and the second moments of the process. We will follow the procedure presented by Van Kampen,
see [44]. We introduce the following difference operators, for any general function φ deﬁned in S:
Mn1φ(n1,n2) = φ(n1 + 1,n2),
Mn2φ(n1,n2) = φ(n1,n2 + 1),
M−1n1 φ(n1,n2) = φ(n1 − 1,n2),
M−1n2 φ(n1,n2) = φ(n1,n2 − 1),
M˜−1n2 φ(n1,n2) = φ(n1,n2 − k). (2.1)
In terms of these operators the forward Kolmogorov equation (1.1) has the following form
dpn1,n2(t)
dt
= (M−1n1 − 1)λ(1)n1,n2 pn1,n2(t) + (M−1n2 − 1)λ(2)n1,n2 pn1,n2(t) + (M˜−1n2 − 1)α(2)n1,n2 pn1,n2(t)
+ (Mn1 − 1)μ(1)n1,n2 pn1,n2(t) + (Mn2 − 1)μ(2)n1,n2 pn1,n2(t). (2.2)
We assume that if the number of T-cells of clonotype i, ni , i ∈ {1,2}, is large enough, then its ﬂuctuations are relatively
small. Thus, the number of cells can be described as a sum of deterministic density plus a small ﬂuctuation. Let Ω be
a parameter which measures the volume of the system. As in [44], we assume that deterministic densities are of order
one and therefore, we can write Ω = NC , where C = O (1) and N is the total number of T-cells present in the periphery
repertoire.
Precisely, by xi(t) we denote a deterministic densities of T-cells of clonotype i and by ξi(t) its ﬂuctuation and we intro-
duce the following change of variables:
ni = Ωxi(t) + Ω 12 ξi(t), for i = 1,2. (2.3)
We assume that the ﬂuctuations are of order Ω
1
2 . We change variables from (n1,n2) to (ξ1, ξ2), so now instead of a proba-
bility distribution p of n1 and n2 we have a probability distribution Π of ξ1 and ξ2, compare [44].
Π(ξ1, ξ2, t) = pn1,n2(t) = p
Ωx1+Ω
1
2 ξ1,Ωx2+Ω
1
2 ξ2
(t).
Differentiating n1(t) and n2(t) we get
dni
dt
= Ω dxi(t)
dt
+ Ω 12 dξi(t)
dt
, for i = 1,2.
Assuming that Ω is large enough we have
dx1(t)
dt
= − 1
Ω
1
2
dξ1(t)
dt
+ O
(
1
Ω
)
. (2.4)
Using the chain rule and (2.4) we obtain
dp
dt
= ∂Π
∂t
− Ω 12 dx1
dt
· ∂Π
∂ξ1
− Ω 12 dx2
dt
· ∂Π
∂ξ2
+ O
(
1
Ω1/2
)
.
From (2.3) one can deduce that
ξi = ni1 − Ω
1
2 xi(t) ⇒ ∂
∂n
= 11
∂
∂ξ
and
∂2
∂n2
= 1
Ω
∂2
∂ξ2
, for i = 1,2.Ω 2 i Ω 2 i 1 1
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Mni = 1+
1
Ω
1
2
∂
∂ξi
+ 1
2Ω
∂2
∂ξ2i
+ O
(
1
Ω
)
, for i = 1,2,
M−1ni = 1−
1
Ω
1
2
∂
∂ξi
+ 1
2Ω
∂2
∂ξ2i
+ O
(
1
Ω
)
, for i = 1,2,
M˜−1n2 = 1−
k
Ω
1
2
∂
∂ξ2
+ k
2
2Ω
∂2
∂ξ22
+ O
(
1
Ω
)
. (2.5)
In terms of new variables the forward Kolmogorov equation (1.1) becomes
∂Π
∂t
− Ω 12
(
dx1
dt
∂Π
∂ξ1
+ dx2
dt
∂Π
∂ξ2
)
=
(
− 1
Ω
1
2
∂
∂ξ1
+ 1
2Ω
∂2
∂ξ21
)
λ
(1)
Ωx1+Ω
1
2 ξ1,Ωx2+Ω
1
2 ξ2
Π
+
(
− 1
Ω
1
2
∂
∂ξ2
+ 1
2Ω
∂2
∂ξ22
)
λ
(2)
Ωx1+Ω
1
2 ξ1,Ωx2+Ω
1
2 ξ2
Π
+
(
− k
Ω
1
2
∂
∂ξ2
+ k
2
2Ω
∂2
∂ξ22
)
α
(2)
Ωx1+Ω
1
2 ξ1,Ωx2+Ω
1
2 ξ2
Π
+
(
Ω−
1
2
∂
∂ξ1
+ 1
2Ω
∂2
∂ξ21
)
μ
(1)
Ωx1+Ω
1
2 ξ1,Ωx2+Ω
1
2 ξ2
Π
+
(
Ω−
1
2
∂
∂ξ2
+ 1
2Ω
∂2
∂ξ22
)
μ
(2)
Ωx1+Ω
1
2 ξ1,Ωx2+Ω
1
2 ξ2
Π + O
(
1
Ω
)
. (2.6)
Next, we introduce into forward Kolmogorov equation (2.6) the birth and death rates. In order to do that we approximate
the birth rates λ(i)n1,n2. It is reasonable to assume that the average number of T-cells per clonotype is proportional to the
system volume. Thus, we assume that 〈n〉 = Ωη, for some constant η. In new variables the birth rates read
λ
(i)
Ωx1+Ω
1
2 ξ1,Ωx2+Ω
1
2 ξ
(i)
2
= ϕi f i
(
Ωx1 + Ω 12 ξ1,Ωx2 + Ω 12 ξ2,Ωνη
)
.
Using the fact that f i are homogenous functions of order 0, the above expression becomes
λ
(i)
Ωx1+Ω
1
2 ξ1,Ωx2+Ω
1
2 ξ
(i)
2
= ϕi f i
(
x1 + 1
Ω
1
2
ξ1, x2 + 1
Ω
1
2
ξ2, νη
)
.
Expanding f i into Taylor series around (x1, x2, νη) we arrive at
λ
(i)
Ωx1+Ω
1
2 ξ1,Ωx2+Ω
1
2 ξ
(i)
2
= ϕi
(
f i(x1, x2) + 1
Ω1/2
(
∂ f i(x1, x2)
∂x1
ξ1 + ∂ f i(x1, x2)
∂x2
ξ2
))
+ O
(
1
Ω
)
. (2.7)
When no confusion may arise we omit the dependence on η to shorten the notation. Introducing (2.7) into the ﬁrst two
terms of the forward Kolmogorov equation (2.6) and keeping only the terms with the two highest power of Ω we obtain(
− 1
Ω
1
2
∂
∂ξi
+ 1
2Ω
∂2
∂ξ2i
)
λ
(i)
Ωx1+Ω
1
2 ξ1,Ωx2+Ω
1
2 ξ2
Π
= 1
Ω1/2
(−ϕi f i(x1, x2))∂Π
∂ξi
+ 1
Ω
(
−ϕi ∂ f i(x1, x2)
∂x1
∂
∂ξi
(ξ1Π) − ϕi ∂ f i(x1, x2)
∂x2
∂
∂ξi
(ξ2Π) + ϕi
2
f i(x1, x2)
∂2
∂ξ2i
Π
)
+ O
(
ϕi
Ω3/2
)
.
Notice, that ϕi describes the amount of APPs and therefore, it is reasonable to assume that it is proportional to the
system volume Ω . We put ϕi = Ωϕ˜i and ﬁnally we arrive at(
− 1
Ω
1
2
∂
∂ξi
+ 1
2Ω
∂2
∂ξ2i
)
λ
(i)
Ωx1+Ω
1
2 ξ1,Ωx2+Ω
1
2 ξ2
Π
= −Ω1/2ϕ˜i f i(x1, x2) ∂Π
∂ξi
+
(
−ϕi ∂ f i(x1, x2)
∂x1
∂
∂ξi
(ξ1Π) − ϕi ∂ f i(x1, x2)
∂x2
∂
∂ξi
(ξ2Π) + ϕi
2
f i(x1, x2)
∂2
∂ξ2i
Π
)
+ O
(
1
1/2
)
. (2.8)Ω
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(2)
n1,n2 = Ωk, where k ∈ N+ .
This assumption means the inﬂux of new naïve T-cells of clonotype 2 from the thymus per volume unit is equal to k.
Introducing α(2)n1,n2 into the third term of the forward Kolmogorov equation (2.6) we obtain(
− k
Ω
1
2
∂
∂ξ2
+ k
2
2Ω
∂2
∂ξ22
)
α
(2)
Ωx1+Ω
1
2 ξ1,Ωx2+Ω
1
2 ξ2
= (−k2Ω 12 )∂Π
∂ξ2
+ k
3
2
∂2
∂ξ22
Π + O
(
1
Ω1/2
)
. (2.9)
The per-cell death rates are assumed to be constant, so for all the cases the death rates, μ(1)n1,n2 and μ
(2)
n1,n2 , are deﬁned as
μ
(1)
n1,n2 = μ1n1 and μ(2)n1,n2 = μ2n2. Introducing μ(1)n1,n2 and μ(2)n1,n2 into the fourth and ﬁfth term of the forward Kolmogorov
equation (2.6) respectively and operating as before we get for i = 1,2(
1
Ω
1
2
∂
∂ξi
+ 1
2Ω
∂2
∂ξ2i
)
μ
(i)
Ωx1+Ω
1
2 ξ1,Ωx2+Ω
1
2 ξ2
= (Ω 12 μi xi)∂Π
∂ξi
+
(
μi
∂
∂ξi
(ξiΠ) + 12μi xi
∂2Π
∂ξ2i
)
+ O
(
1
Ω1/2
)
. (2.10)
Collecting (2.8), (2.9), (2.10) of the Kolmogorov equation (2.6) we arrive at the following equation
−Ω1/2 dx1
dt
∂Π
∂ξ1
− Ω1/2 dx2
dt
∂Π
∂ξ2
+ ∂Π
∂t
= Ω1/2
((−ϕ˜1 f1(x1, x2) + μ1x1)∂Π
∂ξ1
+ (−ϕ˜2 f2(x1, x2) − k2 + μ2x2)∂Π
∂ξ2
)
+
((
μ1 − ϕ˜1 ∂ f1(x1, x2)
∂x1
)
∂
∂ξ1
(ξ1Π) − ϕ˜1 ∂ f1(x1, x2)
∂x2
∂
∂ξ1
(ξ2Π)
+
(
μ2 − ϕ˜2 ∂ f2(x1, x2)
∂x2
)
∂
∂ξ2
(ξ2Π) − ϕ˜2 ∂ f2(x1, x2)
∂x1
∂
∂ξ2
(ξ1Π)
+ 1
2
(
μ1x1 + ϕ˜1 f1(x1, x2)
)∂2Π
∂ξ21
+ 1
2
(
μ2x2 + k3 + ϕ˜2 f2(x1, x2)
)∂2Π
∂ξ22
)
+ O
(
1
Ω1/2
)
. (2.11)
Assuming that the number of cells of both clonotypes is large, we can consider the deterministic process as an approxima-
tion to the stochastic model. Collecting in (2.11) the terms with the highest power of Ω and the proper derivative of Π , we
obtain equations for deterministic densities (see [44]). We arrive at⎧⎪⎪⎨⎪⎪⎩
d
dt
x1(t) = ϕ˜1
(
p1 f1(x1, x2, νη) + (1− p1)g1(x1, ν1η)
)− μ1x1,
d
dt
x2(t) = ϕ˜2
(
p2 f2(x1, x2, νη) + (1− p2)g2(x2, ν2η)
)+ k2 − μ2x2. (2.12)
Collecting terms by Ω0 = 1 we derive the Fokker–Planck equation
∂Π
∂t
= −
(
ϕ˜1
∂ f1(x1, x2)
∂x1
− μ1
)
∂
∂ξ1
(ξ1Π) − ϕ˜1 ∂ f1(x1, x2)
∂x2
∂
∂ξ1
(ξ2Π)
− ϕ˜2 ∂ f2(x1, x2)
∂x1
∂
∂ξ2
(ξ1Π) −
(
ϕ˜2
∂ f2(x1, x2)
∂x2
− μ2
)
∂
∂ξ2
(ξ2Π)
+ 1
2
(
μ1x1 + ϕ˜1 f1(x1, x2)
)∂2Π
∂ξ21
+ 1
2
(
μ2x2 + k3 + ϕ˜2 f2(x1, x2)
)∂2Π
∂ξ22
. (2.13)
From (2.13) we may deduce equation for the moments of ﬂuctuations (see [44])
d
dt
〈ξ1〉 =
(
ϕ˜1
∂ f1(x1, x2)
∂x1
− μ1
)
〈ξ1〉 + ϕ˜1 ∂ f1(x1, x2)
∂x2
〈ξ2〉,
d
dt
〈ξ2〉 = ϕ˜2 ∂ f2(x1, x2)
∂x1
〈ξ1〉 +
(
ϕ˜2
∂ f2(x1, x2)
∂x2
− μ2
)
〈ξ2〉,
d
dt
〈
ξ21
〉= 2(ϕ˜1 ∂ f1(x1, x2)
∂x
− μ1
)〈
ξ21
〉+ 2ϕ˜1 ∂ f1(x1, x2)
∂x
〈ξ1ξ2〉 + μ1x1 + ϕ˜1 f1(x1, x2),1 2
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dt
〈ξ1ξ2〉 = ϕ˜2 ∂ f2(x1, x2)
∂x1
〈
ξ21
〉+(ϕ˜1 ∂ f1(x1, x2)
∂x1
− μ1 + ϕ˜2 ∂ f2(x1, x2)
∂x2
− μ2
)
〈ξ1ξ2〉 + ϕ˜1 ∂ f1(x1, x2)
∂x2
〈
ξ22
〉
,
d
dt
〈
ξ22
〉= 2(ϕ˜2 ∂ f2(x1, x2)
∂x2
− μ2
)〈
ξ22
〉+ 2ϕ˜2 ∂ f2(x1, x2)
∂x1
〈ξ1ξ2〉 + μ2x2 + ϕ˜2 f2(x1, x2). (2.14)
First, we analyze the deterministic part. Having in mind (1.2) we postulate that
f i(x1, x2, η) = pi f (x1, x2, η)xi + (1− pi)gi(xi, η), (2.15)
where f is any continuous and positively homogenous function of degree 0 that decreases in each variable and gi are any
continuous nonincreasing in each variable and positively homogenous functions of degree 0. System (2.12) reads⎧⎪⎪⎨⎪⎪⎩
d
dt
x1(t) = ϕ˜1
(
p1 f (x1, x2, νη)x1 + (1− p1)g1(x1, ν1η)
)− μ1x1,
d
dt
x2(t) = ϕ˜2
(
p2 f (x1, x2, νη)x2 + (1− p2)g2(x2, ν2η)
)+ k2 − μ2x2. (2.16)
Since we assumed η to be constant and we treat it as a parameter, we omit the dependence of f and gi on it and write
f (x1, x2) and gi(xi), respectively.
Although most of the results presented below are valid for a general nonincreasing functions f and gi , we are particularly
interested in the case when λ(i) is given by (1.2). Then the functions f and gi are as follows
f (x1, x2) = 1
x1 + x2 + νη , gi(xi) =
xi
xi + νiη , for i = 1,2. (2.17)
We are particularly interested in the case when clonotype 2 is tumoral, and therefore is a very competitive one, so T-cells
of this clonotype receive survival stimuli from many APPs. This we model taking ν2  1. This yields
g2(x2) = x2
x2 + ν2η .
Although the most of the analysis can be done for a general functions f and gi , we focus on four speciﬁc cases when ν
and ν1 are close to zero or very large:
Case 1: ν  1, ν1 
 1, ν2  1, f (x1, x2) = 1
x1 + x2 + νη , g1(x1) ≈ 1;
Case 2: ν 
 1, ν1 
 1, ν2  1, f (x1, x2) ≈ 1
x1 + x2 , g1(x1) ≈ 1;
Case 3: ν 
 1, ν1  1, ν2  1, f (x1, x2) ≈ 1
x1 + x2 , g1(x1) =
x1
x1 + ν1η ;
Case 4: ν  1, ν1  1, ν2  1, f (x1, x2) = 1
x1 + x2 + νη , g1(x1) =
x1
x1 + ν1η .
Applying the following change of variables
τ = t
μ1
, x(τ ) = μ1
ϕ˜1
x1(t), y(τ ) = μ1
ϕ˜1
x2(t), η¯ = μ1
ϕ˜1
η,
p = p1, α = ϕ˜2
ϕ˜1
, c = k
2
ϕ˜1
, μ = μ2
μ1
, (2.18)
and taking into account that ϕ˜1p1 = ϕ˜2p2 (compare with [41]), the fact that pi f (x1, x1, η)xi + (1− pi)gi(xi, η) are homoge-
nous functions of order 0 for i = 1,2 and then changing again the notation for time from τ to t the model (2.16) can be
written as{
x˙ = pf (x, y)x+ (1− p)g1(x) − x,
y˙ = pf (x, y)y + (α − p)g2(y) + c − μy, (2.19)
where f and gi are general functions that fulﬁll the following properties:
(H1) the function f :R2+ → R+ is a C1-class function such that limx→0 xf (x, y) = limy→0 yf (x, y) = 0 and f (x, y)  0 for
all x, y;
(H2) the functions g1 :R+ → R+ and g2 :R+ → R+ are bounded, non-negative and C1-class;
(H3) the function f is decreasing with respect to the both variables, this is ∂x f (x, y) < 0 and ∂y f (x, y) < 0;
(H4) the function x → gi(x)/x is decreasing, this is ∂x gi(x)/x < 0, for i = 1,2.
Notice, that pi are assumed to be probabilities. Therefore, using (2.18), we may deduce that
0 p min{1,α}. (2.20)
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First we state the following
Theorem 3.1. For any initial data (x0, y0) such that x0 > 0 and y0 > 0 the solutions to the system (2.19) exist for all t > 0, are positive
and unique.
Proof. The Hypotheses (H1) and (H2) together with classical ODE theory imply the local existence and uniqueness of the
solutions. The fact that 0 p  1 and (H2) yield
x˙
(
pf (x, y) − 1)x ⇒ x(t) x0 exp( t∫
0
(
pf
(
x(s), y(s)
)− 1)ds) 0.
Notice, that α > p. In fact, α/p = ϕ˜2/(p1ϕ˜1) = 1/p2 > 1 (we remind that p1ϕ˜1 = p2ϕ˜2). Thus, similarly, we have y(t) 0.
It remains to prove that the solutions are global. Hypotheses (H1)–(H4) imply that there exist constants M1, M2 and M3
such that f (x, y)x max{M1x,M2}, f (x, y)y max{M1 y,M2} and gi(x)  M3. Therefore, the right-hand side of the ﬁrst
equation of (2.19) can be estimated from above by C1x + C2 and the second one by C1 y + C2 for some constants Ci . This
yields that the solutions are global. 
Now, we perform asymptotic analysis for the system (2.19). First, we rule out the presence of limit cycles using the
Bendixon–Dulac criterion. Let D be the ﬁrst quadrant of the phase plane (x, y), namely
D = {(x, y): x > 0, y > 0}.
Now, we formulate the following
Theorem 3.2. If Hypotheses (H1)–(H4) are fulﬁlled then there exists no limit cycle of the system (2.19) in the region D.
Proof. We deﬁne an auxiliary function B(x, y) = 1xy . The function B is continuously differentiable on D , so it fulﬁlls the
suppositions of the Bendixon–Dulac criterion.
Let us denote the right-hand side of the ﬁrst and the second equation of (2.19) by F and G , respectively. This is
F (x, y) = pf (x, y)x+ (1− p)g1(x) − x and G(x, y) = pf (x, y)y + (α − p)g2(y) + c − μy.
We check the sign of
∂
∂x
(BF ) + ∂
∂ y
(BG) = p
y
∂
∂x
f (x, y) + 1− p
y
∂
∂x
(
g1(x)
x
)
+ p
x
∂
∂ y
f (x, y) + α − p
x
∂
∂ y
(
g2(y)
y
)
− c
xy2
.
Hypotheses (H2)–(H4) together with the assumption that 0 p min{1,α} imply that
∂(B(x, y)F (x, y))
∂x
+ ∂(B(x, y)G(x, y))
∂ y
< 0
for all (x, y) ∈ D and therefore, due to Bendixon–Dulac criterion, no limit cycle exists for the system (2.19) in the re-
gion D . 
Next, we look for steady states of system (2.19).
Proposition 3.3. Let Hypotheses (H1)–(H4) be fulﬁlled, let (2.20) hold and the following conditions are fulﬁlled:
lim
y→∞ limx→∞ f (x, y) <
1
p
, lim
x→0
y→∞
f (x, y) μ
p
, (3.1a)
lim
x→∞
g1(x)
x
= 0, lim
x→0
g1(x)
x
>
1
1− p . (3.1b)
Moreover assume that
μ < 1 or lim
x→∞
y→0
f (x, y) 1
p
. (3.1c)
Then there exists a unique positive steady state (x¯, y¯) ∈ D of the system (2.19).
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pf (x, y) + (1− p) g1(x)
x
= 1. (3.2)
Hypotheses (H3) and (H4) yield the left-hand side of Eq. (3.2) is strictly decreasing with respect to x. Let us denote the
left-hand side of (3.2) as H(x, y).
The second condition of (3.1b) ensures that limx→0 H(x, y) > 1. The ﬁrst inequality of (3.1a) and the ﬁrst condition
of (3.1b) yield that limy→∞ limx→∞ pf (x, y) < 1. As H is decreasing with respect to the second variable (because of (H3))
there exists ymin such that limx→∞ H(x, y) < 1 for all y > ymin. Precisely, we deﬁne
ymin = min
{
y > 0: lim
x→∞ H(x, y) < 1
}
.
Therefore, the function x(y) such that H(x(y), y) = 1 is well deﬁned on the interval (ymin,∞). The Implicit Function Theo-
rem implies that x(y) is a decreasing function. In fact, we have
x′(y) = − p
∂ f (x,y)
∂ y |(x(y),y)
(1− p) ∂ f (x,y)
∂x |(x(y),y)
< 0.
Notice also, that if ymin > 0 then limy→y+min limx→∞ pf (x, y) = 1 and therefore,
lim
y→y+min
x(y) = +∞, for ymin > 0. (3.3)
From the second equation of the system (2.19) we have
pf
(
x(y), y
)+ (α − p) g2(y)
y
+ c
y
= μ. (3.4)
From the ﬁrst equation of (2.19) we have pf (x(y), y) = 1− (1− p) g1(x(y))x(y) . Therefore, the left-hand side of Eq. (3.4) reads
h(y) = 1− (1− p) g1(x(y))
x(y)
+ (α − p) g2(y)
y
+ c
y
.
Due to Hypotheses (H3)–(H4) and the fact that x′(y) < 0 we have
h′(y) = −(1− p) d
dx
(
g1(x(y))
x(y)
)∣∣∣∣
x=x(y)
· x′(y) + (α − p) d
dx
(
g2(y)
y
)
− c
y2
< 0.
This implies that the left-hand side of (3.4) is a decreasing function of y.
Notice, that limy→y+min h(y) > μ. In fact, if ymin = 0 then c/y → +∞ as y → y
+
min. If ymin > 0 then (3.3) implies that
limy→y+min h(y) 1 > μ.
Hypothesis (H2) together with the second inequality of (3.1a) imply that
lim
y→∞h(y) = p limy→∞ f
(
x(y), y
)
< μ.
Therefore, there exists a unique solution y¯ such that h( y¯) = μ and thus, the ﬁrst coordinate of the steady state is
x¯ = x( y¯). 
For f and gi given by (2.17) it can be easily seen that for any non-negative x, y (notice, that the function f is well
deﬁned on the half-lines (0,∞) × {0} and {0} × (0,∞))
lim
x→∞ f (x, y) = limy→∞ f (x, y) = 0, limx→∞
g1(x)
x
= 0, lim
x→0
g1
x
= 1
ν1η¯
.
Therefore, all conditions of (3.1) are fulﬁlled with a probable exception for the second condition of (3.1b). This observation
leads to
Corollary 3.4. If the functions f and gi are given by (2.17), then if
ν1η¯ < 1− p
then there exists a unique positive steady state (x¯, y¯) ∈ D of the system (2.19).
Notice, that assumptions of Corollary 3.4 are fulﬁlled if ν1 
 1, this is for the cases 1 and 2, unless p ∼ 1.
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if
lim
y→0 f (0, y) <
1
p
(
1− (1− p) lim
x→0
g1(x)
x
)
(3.5)
there exists no steady state of the system (2.19) in D. However, if g2(y)/y → 0 as y → ∞ and limy→∞ f (0, y) < μ/p, for any y > 0,
then, there exists a unique, semi-trivial steady state of the form (0, y¯).
Proof. Looking at Eq. (3.2) one can notice that limit of the left-hand side of (3.2) as x → 0 is lower then the limit of the
right-hand side. Since the left-hand side is a decreasing function of x and the right-hand side is an increasing function of x,
there is no solution to (3.2) and the ﬁrst part of proposition is proved.
Notice, that the assumption (3.5) implies that g1(0) = 0. In fact, if g(0) > 0 then limx→0 g1(x)/x = +∞ and the inequal-
ity (3.5) would not hold. Thus, for x¯ = 0 the right-hand side of the ﬁrst equation of the system (2.19) is zero. Plugging x¯ = 0
into the second equation of (2.19) we get
pf (0, y) + (α − p) g2(y)
y
+ c
y
= μ.
Hypotheses (H1)–(H4) ensure that the left-hand side of the above equation is decreasing, and the assumptions of the lemma
show that it limits are +∞ as y → 0 and something less then μ as y → +∞. This completes the proof. 
Consider now, f and gi of the form (2.17). Inequality (3.5) reads
p
νη¯
< 1− 1− p
ν1η¯
⇒ ν1
ν2
(νη¯ − p) > 1− p.
Corollary 3.6. If
ν1
ν2
(νη¯ − p) > 1− p
then there exists a semi-trivial steady state of (2.19) of the form (0, y¯).
Notice, that in Corollary 3.6 may be fulﬁlled in the case 4 and cannot be fulﬁlled in the cases 1–3.
In order to check the stability of the unique ﬁxed point (x¯, y¯) we calculate stability matrix J for system (2.19). Remem-
bering that for the steady state the equality pf (x¯, y¯) − 1 = −(1− p) g1(x¯)x¯ holds, we obtain
∂ F (x¯, y¯)
∂x
= p ∂ f (x¯, y¯)
∂x
x¯+ pf (x¯, y¯) + (1− p) ∂ g1(x¯)
∂ x¯
− 1 = (1− p)
(
∂ g1
∂x
(x¯) − g1(x¯)
x¯
)
+ px¯∂ f
∂x
(x¯, y¯).
Similarly, since pf (x¯, y¯) − μ = −(α − p) g2( y¯)y¯ − cy¯ we have
∂G
∂ y
(x¯, y¯) = (α − p)
(
∂ g2
∂ y
( y¯) − g2( y¯)
y¯
)
+ p y¯ ∂ f
∂ y
(x¯, y¯) − c
y¯
.
Easily we can calculate
∂ F
∂ y
(x¯, y¯) = px¯∂ f
∂ y
(x¯, y¯) and
∂G
∂x
(x¯, y¯) = p y¯ ∂ f
∂x
(x¯, y¯).
Hence, the stability matrix J at the steady state (x¯, y¯) is the following:
J =
[
(1− p)( ∂ g1
∂x (x¯) − g1(x¯)x¯ ) + px¯ ∂ f∂x (x¯, y¯) px¯ ∂ f∂ y (x¯, y¯)
p y¯ ∂ f
∂x (x¯, y¯) (α − p)( ∂ g2∂ y ( y¯) − g2( y¯)y¯ ) + p y¯ ∂ f∂ y (x¯, y¯) − cy¯
]
.
Notice that for i = 1,2 we have
g′i(x) −
gi(x)
x
= x
(
g′(x)
x
− gi(x)
x2
)
= x d
dx
(
gi(x)
x
)
< 0. (3.6)
This implies that
tr( J ) = (1− p)x¯ ∂
(
g1(x¯)
¯
)
+ px¯∂ f (x¯, y¯) + (α − p) y¯ ∂
(
g2( y¯)
¯
)
+ p y¯ ∂ f (x¯, y¯) − c¯ < 0.∂x x ∂x ∂ y y ∂ y y
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dx = −∂ f
∂x
(x¯, y¯), dy = −∂ f
∂ y
(x¯, y¯), d1 = − ∂
∂x
(
g1(x¯)
x¯
)
, d2 = − ∂
∂ y
(
g2( y¯)
y¯
)
we obtain
det( J ) = ((1− p)x¯d1 + px¯dx)((α − p) y¯d2 + p y¯dy + c
y¯
)
− p2x¯ y¯dxdy
= ((1− p)x¯d1 + px¯dx)((α − p) y¯d2 + c
y¯
)
+ p(1− p)x¯ y¯dyd1 > 0.
Thus, we may formulate
Theorem 3.7. If the assumptions of Proposition 3.3 are fulﬁlled then a unique positive steady state of the system (2.19) is locally
asymptotically stable.
Theorem 3.8. If Hypotheses (H1)–(H4) are fulﬁlled and there exists semi-trivial steady state (0, y¯) then it is stable if p f (0, y¯) +
(1− p)g′1(0) − 1 < 0 and it is unstable if p f (0, y¯) + (1− p)g′1(0) − 1 > 0.
Proof. In this case the stability matrix reads[ pf (0, y¯) + (1− p)g′1(0) − 1 0
p y¯ ∂ f
∂x (0, y¯) (α − p)( ∂ g2∂ y ( y¯) − g2( y¯)y¯ ) + p y¯ ∂ f∂ y (x¯, y¯) − cy¯
]
.
From (3.6) the thesis follows. 
Now, we analyze the behavior of the null-clines of the system (2.19) and then we sketch the phase portrait of the system.
Null-cline for x It is easy to see that if g1(0) = 0 then the line x = 0 is a null-cline. Let us assume now, that x = 0. Then the
null-cline y(x) fulﬁlls equation
pf
(
x, y(x)
)= 1− (1− p) g1(x)
x
. (3.7)
As we argued before, the left-hand side of (3.7) is a decreasing function of x and the right-hand side is an increasing
function of x. Therefore, for any x > 0 there exists at most one solution y(x) to (3.7). If
lim
(x,y)→0 pf (x, y) < 1− (1− p) limx→0
g1(x)
x
or lim
(x,y)→∞ pf (x, y) > 1− (1− p) limx→∞
g1(x)
x
(3.8)
then there is no solution to (3.7). If both of inequalities (3.8) do not hold then there exists non-empty interval (xmin, xmax)
for which the solution to (3.7) exists and the function y(x) is well deﬁned on this interval. Using the Implicit Function
Theorem it is easy to check that y′(x) < 0. We will show that y(x) → 0 as x → xmax and if xmin > 0 then y(x) → +∞ as
x → xmin and y(x) → y1 > 0 as x → xmin = 0. In fact, the limits exist since y is a monotonic function. Assume that xmin > 0
and y(xmin) < ∞. Then (H3) yields
pf
(
xmin/2, y(x)
)
> pf
(
xmin, y(x)
)= 1− (1− p) g1(xmin)
xmin
therefore, there is a solution to (3.7) for x < xmin. This is a contradiction to the fact that xmin is a lower bound of the domain
of y(x). A similar argument shows that y(x) → 0 as x → xmax. If xmin = 0 then y1 fulﬁlls
lim
x→0 pf (x, y1) = 1− (1− p) limx→0
g1(x)
x
.
Thus, the null-cline is a graph of the decreasing function y = y(x) for (xmin, xmax). Notice, that the necessary and suﬃcient
condition to have xmin = 0 is limx→0 pf (x, ymax) 1− (1− p) limx→0 g1(x)/x.
Null-cline for y The analysis is similar to those above. Here, the line y = 0 is not a null-cline. We have
pf (x, y) = μ − (α − p) g2(y)
y
− c
y
. (3.9)
If
lim pf (x, y) > μ − (α − p) lim
y→∞
g2(y) (3.10)
(x,y)→∞ y
824 J.M. Chrobak et al. / J. Math. Anal. Appl. 386 (2012) 813–829Fig. 1. A sketch of the phase portrait of (2.19) in the case when f and gi are given by (2.17). On the left-hand side the situation when the positive steady
state exists (a usual situation in the cases 1 and 2), on the right-hand side when only semi-trivial steady state exists (a usual situation in the cases 3
and 4).
then there is no solution to (3.9). If the inequality (3.10) does not hold there exists a non-empty interval (ymin, ymax) such
that for any y ∈ (ymin, ymax) there exists a unique solution x(y) to (3.9). Arguing as before we can see that x′(y) < 0 and
lim
y→xmin
x(y) → +∞ and lim
y→ymax
x(y) → 0.
Here we always have ymin > 0 since c/y → ∞ as y → 0.
If the ﬁrst inequality of (3.8) holds, then g1(0) = 0 and x˙(t) < 0 for all x > 0 and y > 0. On the other hand, if the second
inequality of (3.8) is fulﬁlled then x˙(t) > 0 for all (x, y) ∈ D . Similarly, if the inequality (3.10) holds then y˙(t) > 0 for all
(x, y) ∈ D .
From the proof of Proposition 3.3 we may deduce that there exists at most one steady state of (2.19) in D . Together with
the arguments above this leads to the following
Lemma 3.9. If conditions (3.8) and (3.10) do not hold then:
1. if xmin > 0 then there exists a unique steady state of (2.19) in D;
2. if xmin = 0 then if y1 > ymax then there exists a unique steady state of (2.19) in D and if y1 < ymax there is no steady state
of (2.19) in D.
Moreover, if g1(0) = 0 there exists a semi-trivial steady state (0, y¯) of (2.19).
Consider now f and gi of the form (2.17). In this case the second inequality of (3.8) never holds. Moreover, the
inequality (3.10) is never fulﬁlled and therefore, there always exists y-null-cline. The ﬁrst inequality of (3.8) holds if
p/(νη¯) < 1− (1− p)/(ν1η¯). In this case there exists only semi-trivial steady state (0, y¯) (since g1(0) = 0).
If p/(νη¯) > 1− (1− p)/(ν1η¯) then x-null-cline in D exists. If ν1 > 1− p then xmin = 0 and
y1 = pν1
ν1 − (1− p) − ν.
If y1 < ymax, where ymax is a solution to
p
y + νη¯ = μ − (α − p)
1
y + ν2η¯ −
c
y
,
then there exists only semi-trivial steady state (0, y¯) and it is locally stable (see right-hand side picture of Fig. 1). If
y1 > ymax then there exists a positive steady state that is stable and the semi-trivial steady state is unstable (see left-hand
side picture of Fig. 1).
We may summarize: for cases 1 and 2 the phase portrait looks like the one on the left-hand side picture in Fig. 1, except
the case p ∼ 1 when a different behavior is also possible. In case 4, unless p ∼ 0, there exists only semi-trivial steady state,
which is stable. This situation is presented on the right-hand side picture in Fig. 1. Case 3 is the most complicated. The
ﬁrst inequality of (3.8) usually would not be fulﬁlled, unless νη¯ > pν1η¯/(ν1η¯ − (1 − p)). However, in this case xmin = 0
and we have y1 ∼ p. So if ymax is small enough we can have a situation similar to those from cases 1 and 2, with both
coordinates of the positive steady state small, but in general we would have a situation as in case 4 which is presented on
the right-hand side picture in Fig. 1.
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Proof. Taking into account the assumptions of Proposition 3.3, the inequalities (3.8) do not hold. Therefore, as it was shown
above, there exists a null-cline for x deﬁned by the graph of y = y(x) for x ∈ (xmin, xmax). From the ﬁrst equation of the
system (2.19) we have for any y and any x˜ > xmax
pf (x˜, y)x˜+ (1− p)g1(x˜) − x˜ 0.
Similarly inequality (3.10) is not fulﬁlled and from the second equation of the system (2.19):
pf (x, y˜) y˜ + (α − p)g2( y˜) + c − μ y˜  0,
for any y˜ > ymax, where ymax is deﬁned above the corollary.
Let’s now consider region D1 = {(x, y) ∈ R2+: 0  x  xmax, 0  y  ymax}. The above inequalities together with Theo-
rem 3.1 show that D1 invariant for the system (2.19). Theorem 3.1 shows that there exist no limit cycles of the system (2.19)
in the region D1. Proposition 3.3 yields that there exists a unique steady state. Therefore, the Poincaré–Bendixon theorem
implies that this steady state is globally asymptotically stable in D1. Because x1 and y1 can be arbitrary large the thesis of
the corollary follows. 
4. Behavior of the ﬁrst and second moments of the ﬂuctuations near stationary state
In this section we study the behavior of the expected value, variation and covariance of ﬂuctuations near the stationary
steady state of the deterministic system (2.16). We have to consider separately the cases: positive steady state (x¯1, x¯2) (e.g.
if Proposition 3.3 is fulﬁlled) and semi-trivial steady state (0, x¯2) (e.g. if Proposition 3.5 holds). In the previous section we
studied the deterministic model after rescaling and change of the variables from (x1, x2) to (x, y). Here, it would be more
convenient to use the original variables (x1, x2). If x¯1 = 0, then from the ﬁrst equation of the system (2.16) we have
ϕ˜1
(
p1 f (x¯1, x¯2) + (1− p1) g1(x¯1)
x¯1
)
= μ1. (4.1)
The second equation yields, that if x¯2 = 0, then
ϕ˜2
(
p2 f (x¯1, x¯2) + (1− p2) g2(x¯2)
x¯2
)
+ k
2
x¯2
= μ2. (4.2)
Assumption (2.15) implies
∂ f1(x1, x2)
∂x1
= p1 ∂ f (x1, x2)
∂x1
x1 + p1 f (x1, x2) + (1− p1)dg1(x1)
dx1
,
∂ f1(x1, x2)
∂x2
= p1 ∂ f (x1, x2)
∂x2
x1,
∂ f2(x1, x2)
∂x2
= p2 ∂ f (x1, x2)
∂x2
x2 + p2 f (x1, x2) + (1− p2)dg2(x2)
dx2
,
∂ f2(x1, x2)
∂x1
= p2 ∂ f (x1, x2)
∂x1
x2.
Using the above formulas together with (4.1) and (4.2), the two ﬁrst equations of (2.14) read
d
dt
〈ξ1〉 = −(α1a1 + b1)〈ξ1〉 − α1a2〈ξ2〉,
d
dt
〈ξ2〉 = −α2a1〈ξ1〉 −
(
α2a2 + b2 + k
2
x¯2
)
〈ξ2〉 (4.3)
where
a1 = −∂ f (x¯1, x¯2)
∂x1
, a2 = −∂ f (x¯1, x¯2)
∂x2
, α1 = ϕ˜1p1x¯1,
b1 = −ϕ˜1x¯1(1− p1) d
dx1
(
g1(x¯1)
x¯1
)
, b2 = −ϕ˜2 x¯2(1− p2) d
dx2
(
g2(x¯2)
x¯2
)
, α2 = ϕ˜2p2 x¯2. (4.4)
The other three equations of (2.14) can be written as follows:
d
dt
〈
ξ21
〉= −2(α1a1 + b1)〈ξ21 〉− 2α1a2〈ξ1ξ2〉 + 2μ1x1,
d
dt
〈ξ1ξ2〉 = −α2a1
〈
ξ21
〉−((α1a1 + b1) + (α2a2 + b2) + k2
x¯2
)
〈ξ1ξ2〉 − α1a2
〈
ξ22
〉
,
d
dt
〈
ξ22
〉= −2((α2a2 + b2) − k2
x¯2
)〈
ξ22
〉+ 2α2x¯2a1〈ξ1ξ2〉 + 2μ2x¯2 + (k3 − k2). (4.5)
It can be easily seen that the following lemma is true:
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t → +∞.
Proof. Hypotheses (H1)–(H4) imply that ai > 0, bi > 0 and αi > 0. A simple calculation shows the thesis of lemma. 
System for mean of ﬂuctuations (4.3) and for second moments (4.5) are valid for x¯1 > 0 and x¯2 > 0. The latter inequality
is always fulﬁlled, but the ﬁrst one not necessarily. If x¯1 = 0 then we have
∂ f1(0, x¯2)
∂x1
= p1 f (0, x¯2) + (1− p1)g′1(0),
∂ f1(0, x¯2)
∂x2
· 0 = 0,
while the formulas for derivatives of f2 remain as before. Therefore, the expectations of ﬂuctuations fulﬁll the following
system
d
dt
〈ξ1〉 = α0〈ξ1〉,
d
dt
〈ξ2〉 = −α2a1,0〈ξ1〉 −
(
α2a2,0 + b2 + k
2
x¯2
)
〈ξ2〉, (4.6)
where
α0 = ϕ˜1
(
p1 f (0, x¯2) + (1− p1)g′1(0)
)− μ1, a1,0 = −∂ f (0, x¯2)
∂x1
, a2,0 = −∂ f (0, x¯2)
∂x2
.
It can be seen that the trivial steady state of (4.6) is asymptotically stable if and only if
α0 < 0 ⇒ ϕ˜1
(
p1 f (0, x¯2) + (1− p1)dg1(0)
dx1
)
< μ1.
In this case, the system for the second moments reads (we remind that f1(0, x¯2) = 0)
d
dt
〈
ξ21
〉= 2α0〈ξ21 〉,
d
dt
〈ξ1ξ2〉 = −α2a1,0
〈
ξ21
〉−(−α0 + (α2a2,0 + b2) + k2
x¯2
)
〈ξ1ξ2〉,
d
dt
〈
ξ22
〉= −2((α2a2,0 + b2) − k2
x¯2
)〈
ξ22
〉+ 2α2 x¯2a1,0〈ξ1ξ2〉 + 2μ2x¯2 + (k3 − k2). (4.7)
It is easy to see that the steady state of (4.7) is (0,0, σ¯2), where
σ¯2 = 2μ2x¯2 + (k
3 − k2)
2((α2a2,0 + b2) − k2x¯2 )
> 0.
The steady state is stable if α0 < 0 this is when the semi-trivial steady state is stable.
The analysis of the system (4.5) is not complicated. One can ﬁnd a steady state by solving a linear system of algebraic
equation and using Routh–Hurwitz criterion it is possible to determine stability of the steady state. However, because in
general ai and bi can be arbitrary positive numbers, the expressions are very complicated. Since no conclusion can be easily
deduced, we do not see any reason to write down this expressions. The only thing that can be easily deduced from the
form of (4.5) is that 〈ξ1ξ2〉 < 0, since 〈ξ21 〉 > 0 and 〈ξ22 〉 > 0 by probabilistic argument.
Instead of writing a complicated expressions for the steady state of the second moments and their stability we decided
to include some numerical simulations. Following [41] we choose the parameters:
p1 = 0.5, p2 = 0.25, ϕ˜1 = 5, ϕ˜2 = 10, μ1 = 1, μ2 = 1, k = 2, ν2η = 20.
In numerical simulations we consider that x1 and x2 are time-dependent solutions to (2.16).
In Fig. 2 the behavior of the solution to the deterministic system (2.16), expectations of ﬂuctuations and the second
moments are presented for the case νη = 10 and ν1η = 0.1. Here we have
x¯1 ≈ 3.63, x¯2 ≈ 17.83,
〈
ξ21
〉≈ 3.905, 〈ξ22 〉≈ 19.19, 〈ξ1ξ2〉 ≈ −0.28.
We observe that in this case both of the clonotypes survive in the repertoire. That means that if a clonotype is specialized
enough to compete effectively for a survival stimuli from APCs, then it can coexist with the tumoral clonotype of T-cells.
Clonotype 1 of “normal” T-cells follows the rules of shaping of the naïve T-cell repertoire, which require that clonotypes
with low mean niche overlap are maintained, whereas tumorous clonotype 2 does not become extinct, despite of its high
competitiveness (ν2  1). Instead, it achieves some maximum level of growth and stabilizes. Expectations of ﬂuctuations
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Fig. 3. The solution to (2.16) (on the left-hand side panel), to (4.3) (on the middle panel) and to (2.14) (on the right-hand side panel) for the case νη = 0.1
and ν1η = 10.
for both clonotypes are small and tend to zero as t → ∞, hence they become insigniﬁcant after certain t = tmax. Therefore,
the deterministic approximation to the stochastic model is reasonable. Variance of ﬂuctuations for tumorous clonotype 2 is
signiﬁcantly higher than variance for clonotype 1 and it augments with the increase of the parameter k.
In Fig. 3 the behavior of the solution to the deterministic system (2.16), expectations of ﬂuctuations and the second
moments are presented for the case νη = 0.1 and ν1η = 10. Here we have
x¯1 = 0, x¯2 ≈ 20.58,
〈
ξ21
〉≈ 0, 〈ξ22 〉≈ 20.81, 〈ξ1ξ2〉 = 0.
In this case clonotype 1 becomes extinct from the repertoire, meanwhile clonotype 2, as in the previous case, keeps
on growing until some maximum level. In consequence, the naïve T-cell repertoire of an individual is less diverse, which
might cause immune deﬁciency. Evolution in time of expectations of ﬂuctuations and the second moments follow the same
pattern as in the previous case.
5. Conclusions
In this paper we introduced and analyzed a generalized model of precursor T-lymphoblastic lymphoma. From a stochastic
model a deterministic approximation and the Fokker–Planck equation were derived using an expansion of the master equa-
tion [44], which in this case is forward Kolmogorov equation for the continuous-time bivariate Markov process [43]. For
a general deterministic model we have shown existence and uniqueness of global solutions and positive invariance of the
set of solutions for any positive initial conditions. We have also ruled out the presence of limit cycles in the ﬁrst quadrant
of the phase plane. Next, we have formulated assumptions under which the model has a unique, positive steady state and
conditions guaranteeing existence of a unique semi-trivial steady state of the form (0, y¯). We have proved that the unique
steady state is globally stable. From the Fokker–Planck equation systems describing an evolution of the ﬁrst and second
moments of ﬂuctuations have been deduced. We have analyzed an evolution in time of the moments of ﬂuctuations near
stationary state and observed that expectations of ﬂuctuations for both clonotypes are small and tend to zero as t → ∞,
hence the deterministic approximation to the stochastic model is reasonable. As it could be expected, variance of ﬂuctua-
tions for tumorous clonotype 2 increases as the income of new T-cells from the thymus is augmented and is higher than
variance for clonotype 1.
We have concentrated more on the deterministic model than on Fokker–Planck equation because a mathematical analysis
of a nonlinear stochastic model like (1.1)–(1.2) is very diﬃcult and usually hardly possible. On the other hand, the number of
naïve T-cells present in a healthy adult human is approximately 1011 [45] distributed among 107–108 clonotypes [46], which
gives 103–104 of T-cells per clonotype, and this suggest that a deterministic approximation may be useful. Thus, we decided
to use van Kampen approximation to obtain some information on the behavior of the system. We have focused on four
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behavior of both clonotypes. Two scenarios are possible: either both clonotypes of naïve T-cells survive in the repertoire or
the “normal” clonotype becomes extinct, meanwhile the tumorous one is maintained and achieves some maximum level
of growth. This result disagree with the one reported in [41], where it was shown that clonotypes with more speciﬁc
set of receptors, so with niche overlap νi 
 1 have longer life-span. In our model tumoral clonotype is assumed to be
very competitive and yet it would never be removed from the repertoire. This is certainly caused by our assumption of
the constant inﬂux of tumorous T-cells from the thymus. Any other normal clonotype of T-cells can get extinct if it is
not able to compete effectively for survival signal provided by APCs. It seems that “normal” clonotype follows the rules of
shaping of the naïve repertoire of T-cells, whereas the tumorous one avoids this scheme and tends to the maximum possible
expansion.
Taking into account the fact that the discrepancy between this work and [41] is the consequence of augmentation of the
income of new T-cells belonging to clonotype 2 from the thymus, the model supports the hypothesis of mutated precursor
cells as origin of cancer, in particular lymphoma. The chemotherapy which is used nowadays for lymphomas or leukemias
increases the death rate of mutated T-cells. From the model point of view, this would mean an increase of the value of
parameter μ. The results of simulations show that this procedure allows to decrease the total number of cancerous cells, but
is not able to eradicate them. Hence, only therapy directed against stem cells could give a signiﬁcant effect. This conclusion
is in agreement with results of D. Dingli and F. Michor, see [6]. Therefore, an important question would be determination of
the optimal type of therapy for T-cell lymphoma.
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